CoVPN 3003 A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SA — Peter B. Gilbert (FRED HUTC
Project Abstract This proposal outlines the scientific agenda for the COVID-19 Prevention Network (CoVPN) Vaccines Leadership Operations Center (LOC) for implementation of the COVID-19 vaccine efficac
| Project title | CoVPN 3003 A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SA |
|---|---|
| Project number | 3UM1AI068635-15S1 |
| PI name | Peter B. Gilbert |
| Institution | FRED HUTCHINSON CANCER RESEARCH CENTER |
| Funding mechanism | UM1 |
| Agency | NIAID |
| Award amount | $18.32M |
| Fiscal year | 2021 |
| Project start | 2020-12-19T00:00:00 |
| Project end | 2022-03-31T00:00:00 |
| Abstract | Project Abstract This proposal outlines the scientific agenda for the COVID-19 Prevention Network (CoVPN) Vaccines Leadership Operations Center (LOC) for implementation of the COVID-19 vaccine efficac |
| Key terms | <18 year old><18 years of age><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV |
$799/mo
Try GrantRadar →